Radiation Costs Vary Among Medicare Patients with Cancer

 

August 11, 2015  |  

​Cost of radiation therapy among Medicare patients varied most widely because of factors unrelated to a patient or that person’s cancer, report University of California, San Diego School of Medicine researchers in the Journal of Oncology Practice.

radiation equipment

Radiation therapy costs vary among Medicare patients.

Year of diagnosis, location of treatment, clinic type and individual radiation provider accounted for 44 to 61 percent of the variation in cost for patients with breast, lung and prostate cancer therapies, according to the study published August 11 online. Factors associated with the patient or patient’s tumor accounted for less than 3 percent of the variation in the cost of radiation therapy.

“We found that variability in Medicare reimbursement for radiotherapy does not depend on individual characteristics of patients or their cancers,” said James Murphy, MD, assistant professor at UC San Diego School of Medicine and radiation therapist at Moores Cancer Center at UC San Diego Health. “Rather, reimbursement was tied to the provider, geography and technology used to treat patients. This strongly suggests inefficiency within the current Medicare reimbursement framework for radiation therapy.”

Up to two-thirds of patients with cancer receive radiation therapy. Researchers focused on breast, prostate and lung cancers because they represent the most common malignancies treated with radiotherapy.

The cost of radiation therapy was estimated from Medicare reimbursements for outpatient radiation treatment. The total cost of radiation therapy for the 55,288 patients in the study was estimated to be more than $831 million.

“Understanding why costs vary for radiation therapy helps policy makers evaluate the efficiency of the current fee-for-service Medicare reimbursement system. Such insights are likely to shape policy reforms in the near-future,” said Anthony Paravati, MD, first author of the study.

The authors acknowledge that the study does not consider the relationship between cost of radiotherapy and quality of care, therefore higher cost radiation could lead to higher quality radiation. The link between cost and quality of care represents a future research question the authors hope to answer.

Co-authors of this study also include Isabel Boero, Daniel Triplett, Lindsay Hwang, Rayna Matsuno, and Loren Mell of UC San Diego; and Beibei Xu of UC San Diego and Peking University in Beijing.

Funding for this research came, in part, from the National Institutes of Health (TL1TR00098 and KL2 RR031978).


​Care at UC San Diego Health

Cancer

Imaging Services

Radiation Oncology



Media Contact

Yadira Galindo
858-249-0456
ygalindo@ucsd.edu

Share This Article


Related News

11/6/2017
The five University of California medical centers, including Moores Cancer Center at UC San Diego Health, have joined together to recruit 100,000 women in California to be part of WISDOM: a clinical t ...
10/4/2016
Many types of cancer become drug resistant, making them difficult to treat. Researchers with University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy t ...
6/1/2016
Physicians have long used magnetic resonance imaging (MRI) to detect cancer but results of a University of California San Diego School of Medicine study describe the potential use of restriction spect ...
4/27/2016
Urologists at University of California San Diego School of Medicine and Genesis Healthcare Partners have tested a new model of care for patients with low-risk prostate cancer. The evidence-based appro ...



Follow Us